Vittorio Grosso
Vittorio Grosso
IRCCS Policlinico San Matteo, Pavia
Verified email at ateneopv.it
Title
Cited by
Cited by
Year
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
A Moltó, A Etcheto, D Van Der Heijde, R Landewé, F Van den Bosch, ...
Annals of the rheumatic diseases 75 (6), 1016-1023, 2016
1332016
Atherosclerosis and rheumatoid arthritis: more than a simple association
L Cavagna, N Boffini, G Cagnotto, F Inverardi, V Grosso, R Caporali
Mediators of Inflammation 2012, 2012
802012
The multifaceted aspects of interstitial lung disease in rheumatoid arthritis
L Cavagna, S Monti, V Grosso, N Boffini, E Scorletti, G Crepaldi, ...
BioMed research international 2013, 2013
732013
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: extending perspective from old to newer drugs
F De Nard, M Todoerti, V Grosso, S Monti, S Breda, S Rossi, ...
World journal of hepatology 7 (3), 344, 2015
622015
Randomized controlled trials and real-world data: differences and similarities to untangle literature data
S Monti, V Grosso, M Todoerti, R Caporali
Rheumatology 57 (Supplement_7), vii54-vii58, 2018
152018
Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from …
EG Favalli, L Sinigaglia, A Becciolini, V Grosso, R Gorla, C Bazzani, ...
International journal of rheumatic diseases 21 (2), 422-430, 2018
132018
Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients
S Monti, S Breda, V Grosso, M Todoerti, C Montecucco, R Caporali
The Journal of rheumatology 42 (10), 1993-1994, 2015
132015
Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry
M Manara, R Caporali, EG Favalli, V Grosso, F Atzeni, P Sarzi-Puttini, ...
Clinical and Experimental Rheumatology 35 (5), 804-809, 2017
92017
FRI0314 Safety of the newer biological Dmards, TOCILIZUMAB and Abatacept, in rheumatoid arthritis (RA) patients with a history of HBV infection: A real life experience
F De Nard, M Todoerti, V Grosso, S Rossi, R Caporali, C Montecucco
Annals of the Rheumatic Diseases 73 (Suppl 2), 499-499, 2014
32014
AB0788 Treating Axial-Spa to Target: Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Anti-TNFα Agents
S Monti, S Breda, F De Nard, V Grosso, M Todoerti, C Montecucco, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 1162-1163, 2015
22015
Golimumab Therapy Retention Rates in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Data from the Italian Lorhen Registry.: 2512
V Grosso, R Gorla, P Sarzi-Puttini, F Atzeni, R Pellerito, E Fusaro, ...
Arthritis & Rheumatology 66, 2014
22014
AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea
F Iannone, R Caporali, V Grosso, EG Favalli, A Marchesoni, S D’Angelo, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 1296-1297, 2018
12018
SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry
M Sebastiani, A Manfredi, F Iannone, E Gremese, A Bortoluzzi, EG Favalli, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 957-957, 2018
12018
FRI0215 Comparative efficacy and retention rate of tocilizumab and tnf inhibitors used in combination with methotrexate as first-line biologic therapy in rheumatoid arthritis …
EG Favalli, M Biggioggero, PS Puttini, F Atzeni, E Fusaro, V Grosso, ...
Annals of the Rheumatic Diseases 76 (Suppl 2), 564-564, 2017
12017
THU0232 Golimumab Therapy Retention Rates in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Data from the Italian Lorhen Registry
V Grosso, R Gorla, P Sarzi-Puttini, F Atzeni, R Pellerito, E Fusaro, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 280-280, 2015
12015
AB0401 Anxiety and Depression in Patients with Rheumatoid Arthritis Treated with Biological Drugs: Prevalence and Relationship with Disease Activity
V Grosso, F De Nard, S Breda, S Monti, M Todoerti, R Caporali, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 1027-1027, 2015
12015
Diffuse alveolar hemorrhage as a manifestation of Behçet disease
V Grosso, E Boveri, L Bogliolo, C Montecucco, R Caporali
Reumatismo, 138-141, 2013
12013
SAT0622 ROLE OF PREGNANCY IN FLARE AND PROGRESSION INTO DEFINED RHEUMATIC DISEASE IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: RESULTS FROM A MONOCENTRIC …
F Motta, V Ramoni, R Caporali, V Grosso, B Vitolo, S Quaglini, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 1406-1408, 2019
2019
AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry
V Grosso, R Gorla, P Sarzi-Puttini, F Atzeni, R Pellerito, E Fusaro, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 1014-1015, 2016
2016
AB0226 One Year Experience of A Bdmard Spacing Protocol in Real Life Rheumatoid Arthritis Patients
M Todoerti, S Monti, V Grosso, F De Nard, S Breda, I Chiapparoli, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 975-975, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20